Jamie Chlond
Ischemic stroke is a leading cause of mortality and long-term disability worldwide. Despite significant advancements in stroke management, effective therapeutic strategies remain limited. Emerging evidence suggests that the PERK (protein kinase RNA-like endoplasmic reticulum kinase) signaling pathway plays a pivotal role in the pathophysiology of ischemic stroke. This article explores the molecular mechanisms underlying PERK activation during ischemic insult and discusses the therapeutic potential of targeting this pathway in stroke management.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 